Annals of Clinical Biochemistry 1987-03-01

Interference by naproxen in the urinary 5-hydroxyindoleacetic acid assay is due to a metabolite, desmethylnaproxen.

P L Walker, B R Pettit, M Sandler

Index: Ann. Clin. Biochem. 24 ( Pt 2) , 177-81, (1987)

Full Text: HTML

Abstract

Interference by naproxen in the spectrophotometric assay for urinary 5-hydroxyindoleacetic acid has been investigated. Gas chromatography-mass spectrometry demonstrated that ingestion of naproxen was associated with the production of four urinary components, unchanged drug and three metabolites, the major one being desmethylnaproxen. Unlike naproxen, this metabolite reacted in the spectrophotometric assay giving a product with the same absorption spectrum as that observed in urine samples obtained after naproxen ingestion. Unlike 5-hydroxyindoleacetic acid, the colour due to desmethylnaproxen is thermolabile and so the interference may be overcome by performing the incubation at 100 degrees C.


Related Compounds

Related Articles:

The pharmacokinetic profile of naproxen suppository in man.

1988-04-01

[Int. J. Clin. Pharmacol. Ther. Toxicol. 26(4) , 190-3, (1988)]

Sulphation of o-desmethylnaproxen and related compounds by human cytosolic sulfotransferases.

2005-12-01

[Br. J. Clin. Pharmacol. 60(6) , 632-40, (2005)]

High-performance liquid chromatographic determination of 6-desmethylnaproxen sulfate in human plasma.

[J. Chromatogr. A. 383(2) , 449-55, (1986)]

Naproxen metabolites interfere with certain bilirubin assays: elimination of interference by using a Roche bilirubin assay on the Hitachi 917 analyzer.

2010-06-01

[Am. J. Clin. Pathol. 133(6) , 878-83, (2010)]

Lipid peroxidation and chemiluminescence during naproxen metabolism in rat liver microsomes.

1994-12-01

[Hum. Exp. Toxicol. 13(12) , 831-8, (1994)]

More Articles...